Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |